EXPLORE CONNECTIONS

[Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse events. Data from the Evaluation of Platelets IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial].

Follow the relationships that help you find your next source.

Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.